X

Trial Profile

Phase 2 trial of NOV-002 [glutathione/cisplatin] with carboplatin in women with recurrent and platinum- resistant tumors of Mullerian origin,

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 17 Mar 2015

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Glutathione/cisplatin (Primary) ; Carboplatin
Indications Ovarian cancer
Focus Therapeutic Use
Sponsors Cellectar Biosciences

Most Recent Events

11 Feb 2014 Novelos Therapeutics now known as Cellectar Biosciences
08 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
03 Jun 2008 Interim results presented at the 2008 annual meeting of the American Society of Clinical Oncology (ASCO).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com